Beijing, China

Jinlong Bai

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017-2020

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovative Contributions of Inventor Jinlong Bai

Introduction

Jinlong Bai, an inventive mind hailing from Beijing, China, has made significant contributions to the field of pharmaceutical development through his innovative approach to drug design. With a total of three patents under his belt, Bai has focused on creating compounds that target specific protein activities, paving the way for advanced therapeutic options.

Latest Patents

Among his notable inventions, two latest patents stand out. The first is titled "Heterocyclic ring derivatives useful as SHP2 inhibitors." This patent introduces novel pyrazine derivatives designed to act as SHP2 inhibitors. The synthesis of these compounds and their application for treating SHP2-mediated disorders showcase Bai's commitment to addressing complex medical challenges.

The second patent, "Protein tyrosine kinase modulators and methods of use," features heterocyclic pyrimidine compounds that selectively modulate mutant forms of the epidermal growth factor receptor (EGFR) and ALK kinase activity. This invention reveals the potential of pyrimidines to inhibit and regulate kinase receptors, offering promising treatment methods for diseases associated with protein kinase activity, such as non-small cell lung cancer.

Career Highlights

Jinlong Bai's career has been marked by his associations with prominent pharmaceutical companies, including Betta Pharmaceuticals Co., Ltd. and Jacobio Pharmaceuticals Co., Ltd. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in targeted therapies.

Collaborations

Throughout his career, Bai has collaborated with notable professionals in the field, including Shaojing Hu and Xiangyong Liu. These partnerships have facilitated the exchange of ideas and further propelled his research efforts into creating impactful pharmaceutical innovations.

Conclusion

Jinlong Bai stands out as a remarkable inventor whose dedication to developing effective medical treatments is evident through his patents and collaborations. His work on SHP2 inhibitors and protein tyrosine kinase modulators reflects the significant impact that innovative thinking can have on healthcare. As the pharmaceutical landscape continues to evolve, his contributions will undoubtedly play a critical role in shaping future therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…